Print this page    •   Back to Web version of article

International News
Conference Examines Lagging Ethical Guidelines in Face of Expanding Clinical Trials in Developing Countries

June 29, 2011

SciDev.Net reports on the 7th World Conference of Science Journalists, taking place this week in Qatar, where participants discussed how the number of clinical trials in developing countries is surging despite legal and ethical frameworks often not being in place.

"By 2008, for example, there were three times as many developing countries participating in clinical trials registered with the US Food and Drug Administration (FDA) than there were in the entire period between 1948 and 2000, with many 'transitional' countries, such as Brazil, China, India, Mexico and South Africa, taking part. For the pharmaceutical industry, the attractions are the lower costs and the availability of 'treatment-naive' patients, who are much less likely to have been previously exposed to drugs or trials," SciDev.Net writes (Leighton, 6/28). The news service's blog has several other updates from the conference.

Back to other news for June 2011

This information was reprinted from with permission from the Henry J. Kaiser Family Foundation. You can view the entire Kaiser Daily Global Health Policy Report, search the archives, and sign up for email delivery. © Henry J. Kaiser Family Foundation. All rights reserved.

This article was provided by Henry J. Kaiser Family Foundation. It is a part of the publication Kaiser Daily Global Health Policy Report. You can find this article online by typing this address into your Web browser:

General Disclaimer: is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.